New treatment path for lasting Lyme disease symptoms: Research | Health - Hindustan Times
close_game
close_game

New treatment path for lasting Lyme disease symptoms: Research

ANI | | Posted by Tapatrisha Das, Washington
Apr 20, 2024 03:20 PM IST

The study shows that a type of drug can significantly reduce inflammation and cell death in brain and nerve tissue samples infected with Borrelia burgdorferi.

Tulane University researchers have discovered a promising new strategy for treating persistent neurological symptoms associated with Lyme disease, providing hope to patients who continue to suffer from the bacterial infection even after receiving antibiotic treatment.

Lyme disease, caused by the bacteria Borrelia burgdorferi and spread through tick bites, can produce a variety of symptoms, including those affecting the central and peripheral neurological systems.(Shutterstock)
Lyme disease, caused by the bacteria Borrelia burgdorferi and spread through tick bites, can produce a variety of symptoms, including those affecting the central and peripheral neurological systems.(Shutterstock)

The findings were published in Frontiers in Immunology.

Unlock exclusive access to the latest news on India's general elections, only on the HT App. Download Now! Download Now!

Lyme disease, caused by the bacteria Borrelia burgdorferi and spread through tick bites, can produce a variety of symptoms, including those affecting the central and peripheral neurological systems.

While medications can effectively treat the infection in most cases, a portion of people continue to endure symptoms such as memory loss, exhaustion, and pain--a condition known as post-treatment Lyme disease syndrome.

Principal investigator Geetha Parthasarathy, PhD, an assistant professor of microbiology and immunology at the Tulane National Primate Research Center, has discovered that fibroblast growth factor receptor inhibitors, a type of drug previously studied in the context of cancer, can significantly reduce inflammation and cell death in brain and nerve tissue samples infected with Borrelia burgdorferi.

This discovery suggests that targeting FGFR pathways may offer an exciting new therapeutic approach to addressing persistent neuroinflammation in patients with post-treatment Lyme disease syndrome.

"Our findings open the door to new research approaches that can help us support patients suffering from the lasting effects of Lyme disease," Parthasarathy said.

“By focusing on the underlying inflammation that contributes to these symptoms, we hope to develop treatments that can improve the quality of life for those affected by this debilitating condition.”

Catch every big hit, every wicket with Crick-it, a one stop destination for Live Scores, Match Stats, Quizzes, Polls & much more. Explore now!.

Catch your daily dose of Fashion, Taylor Swift, Health, Festivals, Travel, Relationship, Recipe and all the other Latest Lifestyle News on Hindustan Times Website and APPs.
This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Monday, May 20, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On